Literature DB >> 11057500

Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts.

A Dumoulin1, E Mazars, N Seguy, D Gargallo-Viola, S Vargas, J C Cailliez, E M Aliouat, A E Wakefield, E Dei-Cas.   

Abstract

Pneumocystis carinii organisms constitute a large group of heterogeneous atypical microscopic fungi that are able to infect immunocompromised mammals by an airborne route and to proliferate in their lungs, inducing Pneumocystis carinii pneumonia. This pneumonia remains a crucial epidemiological challenge, since neither the source of Pneumocystis carinii infection in humans nor the process by which humans become infected has been clearly established. Polymerase chain reaction (PCR) assays have shown that profoundly immunosuppressed patients without pneumocystosis can be subclinically infected with Pneumocystis. Other PCR-based studies have suggested that healthy immunocompetent hosts are not latent carriers of the parasite. However, recent reports have indicated that Pneumocystis carinii can persist for limited periods in the lungs of convalescent rats after recovery from corticosteroid-induced pneumocystosis, and also that immunocompetent mammals can be transiently parasitized by Pneumocystis carinii after close contact with hosts with Pneumocystis carinii pneumonia. Can transiently parasitized hosts be a source of infection for immunosuppressed hosts? In order to investigate this important clinical question, the ability of immunocompetent BALB/c mice, which were carrying subclinical levels of Pneumocystis carinii, to transmit the infection by the airborne route to highly susceptible, uninfected mice with severe combined immunodeficiency was studied. The results indicated that the immunocompetent mice, transiently parasitized by Pneumocystis carinii organisms after close contact with Pneumocystis carinii-infected mice, were able to transmit the infection to Pneumocystis carinii-free mice with severe combined immunodeficiency.

Entities:  

Mesh:

Year:  2000        PMID: 11057500     DOI: 10.1007/s100960000354

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  39 in total

1.  Clearance of Pneumocystis murina infection is not dependent on MyD88.

Authors:  Chiara Ripamonti; Lisa R Bishop; Jun Yang; Richard A Lempicki; Joseph A Kovacs
Journal:  Microbes Infect       Date:  2014-03-25       Impact factor: 2.700

Review 2.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  Genotypes at the internal transcribed spacers of the nuclear rRNA operon of Pneumocystis jiroveci in nonimmunosuppressed infants without severe pneumonia.

Authors:  Anne Totet; Jean-Claude Pautard; Christian Raccurt; Patricia Roux; Gilles Nevez
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

4.  Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia.

Authors:  R F Miller; H E Ambrose; A E Wakefield
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 5.  Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis.

Authors:  James A Grubbs; John W Baddley
Journal:  Curr Rheumatol Rep       Date:  2014-10       Impact factor: 4.592

6.  Pneumocystis carinii f. sp. hominis is not infectious for SCID mice.

Authors:  Isabelle Durand-Joly; El Moukhtar Aliouat; Céline Recourt; Karine Guyot; Nadine François; Michèle Wauquier; Daniel Camus; Eduardo Dei-Cas
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

7.  Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study.

Authors:  N A Maskell; D J Waine; A Lindley; J C T Pepperell; A E Wakefield; R F Miller; R J O Davies
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

8.  Primary pneumocystis infection in infants hospitalized with acute respiratory tract infection.

Authors:  Hans Henrik Larsen; Marie-Louise von Linstow; Bettina Lundgren; Birthe Høgh; Henrik Westh; Jens D Lundgren
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

9.  Characterizing Pneumocystis in the lungs of bats: understanding Pneumocystis evolution and the spread of Pneumocystis organisms in mammal populations.

Authors:  Haroon Akbar; Claire Pinçon; Cecile-Marie Aliouat-Denis; Sandra Derouiche; Maria-Lucia Taylor; Muriel Pottier; Laura-Helena Carreto-Binaghi; Antonio E González-González; Aurore Courpon; Véronique Barriel; Jacques Guillot; Magali Chabé; Roberto O Suarez-Alvarez; El Moukhtar Aliouat; Eduardo Dei-Cas; Christine Demanche
Journal:  Appl Environ Microbiol       Date:  2012-09-21       Impact factor: 4.792

10.  Healthcare worker occupation and immune response to Pneumocystis jirovecii.

Authors:  Renuka Tipirneni; Kieran R Daly; Leah G Jarlsberg; Judy V Koch; Alexandra Swartzman; Brenna M Roth; Peter D Walzer; Laurence Huang
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.